Regulations.gov document
Risk Management Plans to Mitigate the Potential for Drug Shortages Guidance for Industry…
Other · FDA-2022-D-0277 · posted May 20, 2022
Key facts
| Document ID | FDA-2022-D-0277-0002 |
|---|---|
| Title | Risk Management Plans to Mitigate the Potential for Drug Shortages Guidance for Industry DRAFT GUIDANCE |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2022-D-0277 |
| Posted | May 20, 2022 |
| Comment period opens | May 20, 2022 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: